製品名:methyl 2-(4-bromophenyl)acetate

IUPAC Name:methyl 2-(4-bromophenyl)acetate

CAS番号:41841-16-1
分子式:C9H9BrO2
純度:95%+
カタログ番号:CM107979
分子量:229.07

包装単位 有効在庫 価格(USD) 数量
CM107979-500g in stock Ʀȁȁ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:41841-16-1
分子式:C9H9BrO2
融点:-
SMILESコード:O=C(OC)CC1=CC=C(Br)C=C1
密度:
カタログ番号:CM107979
分子量:229.07
沸点:
MDL番号:MFCD00126844
保管方法:Keep in a dry and a tight container and store at ambient temperature

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Carbonyl Compounds
In organic chemistry, a carbonyl group is a functional group with the formula C=O, composed of a carbon atom double-bonded to an oxygen atom, and it is divalent at the C atom. It is common to several classes of organic compounds (such as aldehydes, ketones and carboxylic acids), as part of many larger functional groups. A compound containing a carbonyl group is often referred to as a carbonyl compound.
Aprocitentan
New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023.
Aprocitentan is an investigational, novel, oral, dual endothelin receptor antagonist (ERA), which potently inhibits the binding of ET-1 to ETA and ETB receptors. Aprocitentan has a low potential for drug-drug interaction and a mechanism of action that is ideally suited for the pathophysiology of resistant hypertension.
A new drug application (NDA) for aprocitentan was accepted for review by the US FDA.

Related Products